UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.687

Sortiert nach

Advances in understanding large‐scale responses of the water cycle to climate change

Annals of the New York Academy of Sciences, 2020-07, Vol.1472 (1), p.49-75

2020

Volltextzugriff (PDF)

Toward accounting for ecoclimate teleconnections: intra- and inter-continental consequences of altered energy balance after vegetation change

Landscape ecology, 2016-01, Vol.31 (1), p.181-194

2016

Volltextzugriff (PDF)

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

Annals of oncology, 2014-07, Vol.25 (7), p.1428-1436

2014

Volltextzugriff (PDF)

Intratumoral (IT) Injection of the TLR9 agonist tilsotolimod (IMO-2125) in combination with ipilimumab (ipi) triggers durable responses in PD-1 inhibitor refractory metastatic melanoma (rMM): Results from a multicenter, phase I/II study

Annals of oncology, 2018-10, Vol.29, p.viii442-viii442

2018

Volltextzugriff (PDF)

ILLUMINATE 301: A randomized phase III comparison of IMO-2125 with ipilimumab (ipi) versus ipi alone in subjects with anti PD 1 refractory melanoma

ANNALS OF ONCOLOGY, 2018-10, Vol.29, p.viii466-viii466

2018

Volltextzugriff (PDF)

Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial

Annals of oncology, 2015-02, Vol.26 (2), p.415-421

2015

Volltextzugriff (PDF)

Application of magnetron sputtering for producing ceramic coatings on implant materials

Clinical oral implants research, 1993-03, Vol.4 (1), p.28-34

1993

Volltextzugriff (PDF)

A comprehensive approach for evaluating telemedicine-delivered multidisciplinary breast cancer meetings in southern Scotland

Journal of telemedicine and telecare, 2005-01, Vol.11 Suppl 1, p.71

2005

Volltextzugriff (PDF)

Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group

BMJ (Online), 2004-01, Vol.328 (7430), p.22-24

International edition, 2004

Volltextzugriff (PDF)

RM1 - Adjusting For Treatment Switching in Rcts – Identifying, Analysing and Justifying Appropriate Methods: a Case Study in Metastatic Melanoma

Value in health, 2015-11, Vol.18 (7), p.A338-A338

2015

Volltextzugriff (PDF)

Adjusting For Treatment Switching in Rcts – Identifying, Analysing and Justifying Appropriate Methods: a Case Study in Metastatic Melanoma

Value in health, 2015-11, Vol.18 (7), p.A338-A338

2015

Volltextzugriff (PDF)

1245PDIntratumoral (IT) Injection of the TLR9 agonist tilsotolimod (IMO-2125) in combination with ipilimumab (ipi) triggers durable responses in PD-1 inhibitor refractory metastatic melanoma (rMM): Results from a multicenter, phase I/II study

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1306TiPILLUMINATE 301: A randomized phase III comparison of IMO-2125 with ipilimumab (ipi) versus ipi alone in subjects with anti PD 1 refractory melanoma

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Attitudes of breast cancer professionals to conventional and telemedicine-delivered multidisciplinary breast meetings

Journal of telemedicine and telecare, 2005-01, Vol.11 Suppl 2, p.S29

2005

Volltextzugriff (PDF)

A Phase 1/2 trial of intratumoral (i.t.) IMO-2125 (IMO) in combination with checkpoint inhibitors (CPI) in PD-(L)1-refractory melanoma

Annals of oncology, 2017-09, Vol.28, p.v421-v421

2017

Volltextzugriff (PDF)

Frequency ratio measurements at 18-digit accuracy using an optical clock network

Nature (London), 2021-03, Vol.591 (7851), p.564-569

2021

Volltextzugriff (PDF)

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

The New England journal of medicine, 2021-06, Vol.384 (23), p.2187-2201

2021

Volltextzugriff (PDF)

The Special Operations Aviation flight medic

Military medicine, 2001-05, Vol.166 (5), p.401-404

2001

Volltextzugriff (PDF)

An Update on Overall Survival (Os) and Follow-On Therapies in Break-3, a Phase Iii, Randomized Trial: Dabrafenib (D) Vs. Dacarbazine (Dtic) in Patients (Pts) with Braf V600E Mutation-Positive Metastatic Melanoma (Mm)

Annals of oncology, 2014-09, Vol.25, p.iv378

2014

Volltextzugriff (PDF)

1092PDAN UPDATE ON OVERALL SURVIVAL (OS) AND FOLLOW-ON THERAPIES IN BREAK-3, A PHASE III, RANDOMIZED TRIAL: DABRAFENIB (D) VS. DACARBAZINE (DTIC) IN PATIENTS (PTS) WITH BRAF V600E MUTATION-POSITIVE METASTATIC MELANOMA (MM)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv378-iv378

2014

Volltextzugriff (PDF)

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

The New England journal of medicine, 2021-02, Vol.384 (6), p.533-540

2021

Volltextzugriff (PDF)

Evaluation of new treatments in radiation oncology: are they better than standard treatments?

JAMA : the journal of the American Medical Association, 2005-02, Vol.293 (8), p.970

2005

Volltextzugriff (PDF)

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers

Clinical infectious diseases, 2021-08, Vol.73 (3), p.e699-e709

2021

Volltextzugriff (PDF)

Data Resource Profile: the Children and Young People with Long COVID (CLoCk) Study

International journal of epidemiology, 2024-02, Vol.53 (1)

2024

Volltextzugriff (PDF)

Variation in access and prescription of vedolizumab and ustekinumab in paediatric patients with inflammatory bowel disease: a UK-wide study

Archives of disease in childhood, 2023-12, Vol.108 (12), p.994

2023

Volltextzugriff (PDF)

1 – 25 von 1.687

Suche als RSS-Feed

Aktive Filter

KollektionBusiness Source Ultimate

SpracheKatalanisch

KollektionWK Lippincott Williams & Wilkins–Connect here FIRST to enable access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.613)
Mit Volltextzugriff
(1.471)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(977)
Life Sciences & Biomedicine
(904)
Humans
(706)
Male
(440)
Female
(430)
Biological And Medical Sciences
(293)
Animals
(281)
Adult
(242)
Medical Sciences
(205)
Middle Aged
(176)
Social Sciences
(161)
Psychology
(151)
Neurosciences & Neurology
(127)
Adolescent
(112)
Psychiatry
(112)
Aged
(108)
Psychology. Psychoanalysis. Psychiatry
(106)
Neurosciences
(102)
Fundamental And Applied Biological Sciences. Psychology
(96)
General & Internal Medicine
(91)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clinical And Experimental Optometry
(80)
Journal Of Personality And Social Psychology
(44)
Nature
(40)
Bmj
(35)
Journal Of Clinical Oncology
(31)
British Medical Journal
(29)
The American Journal Of Psychiatry
(29)
Human Reproduction
(25)
Science
(25)
Bmj. British Medical Journal
(24)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Advances in understanding large‐scale responses of the water cycle to climate change

Toward accounting for ecoclimate teleconnections: intra- and inter-continental consequences of altered energy balance after vegetation change

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

Intratumoral (IT) Injection of the TLR9 agonist tilsotolimod (IMO-2125) in combination with ipilimumab (ipi) triggers durable responses in PD-1 inhibitor refractory metastatic melanoma (rMM): Results from a multicenter, phase I/II study

ILLUMINATE 301: A randomized phase III comparison of IMO-2125 with ipilimumab (ipi) versus ipi alone in subjects with anti PD 1 refractory melanoma

Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial

Application of magnetron sputtering for producing ceramic coatings on implant materials

A comprehensive approach for evaluating telemedicine-delivered multidisciplinary breast cancer meetings in southern Scotland

Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group

RM1 - Adjusting For Treatment Switching in Rcts – Identifying, Analysing and Justifying Appropriate Methods: a Case Study in Metastatic Melanoma

Adjusting For Treatment Switching in Rcts – Identifying, Analysing and Justifying Appropriate Methods: a Case Study in Metastatic Melanoma

1245PDIntratumoral (IT) Injection of the TLR9 agonist tilsotolimod (IMO-2125) in combination with ipilimumab (ipi) triggers durable responses in PD-1 inhibitor refractory metastatic melanoma (rMM): Results from a multicenter, phase I/II study

1306TiPILLUMINATE 301: A randomized phase III comparison of IMO-2125 with ipilimumab (ipi) versus ipi alone in subjects with anti PD 1 refractory melanoma

Attitudes of breast cancer professionals to conventional and telemedicine-delivered multidisciplinary breast meetings

A Phase 1/2 trial of intratumoral (i.t.) IMO-2125 (IMO) in combination with checkpoint inhibitors (CPI) in PD-(L)1-refractory melanoma

Frequency ratio measurements at 18-digit accuracy using an optical clock network

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

The Special Operations Aviation flight medic

An Update on Overall Survival (Os) and Follow-On Therapies in Break-3, a Phase Iii, Randomized Trial: Dabrafenib (D) Vs. Dacarbazine (Dtic) in Patients (Pts) with Braf V600E Mutation-Positive Metastatic Melanoma (Mm)

1092PDAN UPDATE ON OVERALL SURVIVAL (OS) AND FOLLOW-ON THERAPIES IN BREAK-3, A PHASE III, RANDOMIZED TRIAL: DABRAFENIB (D) VS. DACARBAZINE (DTIC) IN PATIENTS (PTS) WITH BRAF V600E MUTATION-POSITIVE METASTATIC MELANOMA (MM)

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

Evaluation of new treatments in radiation oncology: are they better than standard treatments?

The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers

Data Resource Profile: the Children and Young People with Long COVID (CLoCk) Study

Variation in access and prescription of vedolizumab and ustekinumab in paediatric patients with inflammatory bowel disease: a UK-wide study

Aktive Filter

Suchergebnisse filtern